Moffitt logo

Clinical Trials Search

Clinical Trial 17723

Cancer Type: Thoracic
Study Type: Diagnostic

Phase: N/A
Principal Investigator: Schabath, Matthew

Call 813-745-6100
or 1-800-679-0775 Learn More

Study Title

Expansion of Enduring Infrastructure to Support Lung Cancer Screening Research


This is a questionnaire study. The data obtained from this study will improve our understanding of the factors that are associated with an increased risk of lung cancer and may lead to new ways to screen and prevent lung cancer.


Our long term objective is to establish a high throughput radiomics lung cancer screening pipeline that will extract radiomic features from CT images in real time. To reach this objective this protocol will prospectively consent and follow up lung cancer screening patients at the Moffitt Cancer Center and Moffitt International Plaza. The overarching goal of this research is to test the hypothesis that radiomic features derived from CT screening images alone, and in combination with risk factor and genetic data, are predictive of lung cancer risk in a lung screening population.




Inclusion Criteria

Inclusion Criteria:

  • Our goal is to recruit and consent participants from approximately 200 computed tomography (CT) lung cancer screening appointments per year.
  • Greater than 18 years of age

  • Exclusion Criteria

    Exclusion Criteria:

  • Do not understand English or Spanish
  • Exhibit signs of cognitive impairment

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.